Somalogic stock.

7 hours ago · SOUTH SAN FRANCISCO, Calif. and BOULDER, Colo., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – and SomaLogic, Inc. (Nasdaq: SLGC), a leader in data-driven proteomics technology, today announced that the companies have set a date for their respective Special Meetings of ...

Somalogic stock. Things To Know About Somalogic stock.

Healthcare company SomaLogic, Inc. (SLGC) operates as a protein biomarker discovery and clinical diagnostics firm, developing slow off-rate modified aptamers (SOMAmers) and offering proprietary SomaScan services.Renowned investor Cathie Wood’s firm ARK Invest owns 11.02 million SLGC shares for a total value of $31.95 …Track SomaLogic Inc - Ordinary Shares - Class A (SLGC) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsSomaLogic and Standard BioTools announced on Wednesday that the companies would combine in an all-stock merger. The combined company will have a pro forma equity value of over $1 billion.Establishing ownership of stock depends on how the stock was purchased, according to the Securities and Exchange Commission. A brokerage firm may have purchased the stock or it may have been bought directly from the company.

EXEL. Exelixis, Inc. 21.50. +0.28. +1.32%. In this piece, we will take a look at the 12 best biotechnology stocks to buy under $20. For more stocks, head on over to 5 Best Biotech Stocks To Buy ...

Mar 28, 2023 · SomaLogic, Inc. is a commercial-stage proteomics company. The Company has built an integrated proteomics platform, which offers throughput proteomics analysis with broad proteome coverage. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate ... View the latest SomaLogic Inc. (SLGC) stock price, news, historical charts, analyst ratings and financial information from WSJ.

SomaLogic shareholders will receive 1.11 shares of Standard BioTools common stock for each share of SomaLogic common stock owned. Upon the close of the deal, Standard BioTools shareholders will ...According to the issued ratings of 5 analysts in the last year, the consensus rating for SomaLogic stock is Hold based on the current 3 hold ratings and 2 buy ratings for SLGC. The average twelve-month price prediction for SomaLogic is $4.26 with a high price target of $7.00 and a low price target of $2.30. Learn more on SLGC's analyst rating ...SomaLogic last released its earnings results on November 8th, 2023. The reported ($0.12) EPS for the quarter, beating the consensus estimate of ($0.17) by $0.05. The firm had revenue of $22.05 million for the quarter, compared to analysts' expectations of $20.45 million. SomaLogic has generated ($0.69) earnings per share over the last year ...0001104659-23-106609.txt : 20231004 0001104659-23-106609.hdr.sgml : 20231004 20231004081127 ACCESSION NUMBER: 0001104659-23-106609 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT C

When picking the best stocks under $10 to buy, it's important to identify fundamentally strong and non-speculative stocks. These are fundamentally strong and non-speculative stocks that are under $10 Since the meme stock euphoria in 2020, i...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT...

Income Statement for Somalogic Inc (SLGC) with Annual and Quarterly reports. Income Statement for Somalogic Inc (SLGC) ... Stock Market Overview Market Momentum Market Performance Top 100 Stocks Today's Price Surprises New Highs & Lows Economic Overview Earnings Within 7 Days Earnings & Dividends Stock Screener.Ark Investment Management has been accumulating the stock recently and owns 3.1% of SomaLogic stock. The current market cap of the company is $2.03B and the enterprise value is $1.8B. Over a long ...SomaLogic is a leading commercial-stage proteomics company. On October 4, 2023, Standard BioTools and SomaLogic announced a merger whereby Standard BioTools will issue new shares of stock to existing SomaLogic shareholders. After the merger, which is expected to close in early 2024, current Standard BioTools …Their SLGC share price targets range from $2.30 to $7.00. On average, they expect the company's share price to reach $4.26 in the next year. This suggests a …Healthcare company SomaLogic, Inc. (SLGC) operates as a protein biomarker discovery and clinical diagnostics firm, developing slow off-rate modified aptamers (SOMAmers) and offering proprietary SomaScan services.Renowned investor Cathie Wood’s firm ARK Invest owns 11.02 million SLGC shares for a total value of $31.95 …

SomaLogic, Inc. Class A Common Stock (SLGC) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Jefferies Downgrades SomaLogic to Hold From Buy, Adjusts Price Target to $2.30 From $3.50. Oct. 05. MT. Canaccord Genuity Downgrades SomaLogic to Hold From Buy, Cuts Price Target to $2.50 From $5. Sep. 25. MT. Canaccord Genuity Adjusts Price Target on SomaLogic to $5 From $6, Maintains Buy Rating. Mar. 29. Nov 29, 2023 · After this action, Taich Adam now owns 238,643 shares of SomaLogic Inc, valued at $50,286 using the latest closing price. Gutierrez Ruben, the General Counsel of SomaLogic Inc, sale 9,211 shares at $2.33 during a trade that took place back on Sep 15, which means that Gutierrez Ruben is holding 110,534 shares at $21,460 based on the most recent ... 7 hours ago · Information concerning SomaLogic's directors and executive officers, including their ownership of SomaLogic securities, is set forth in the joint proxy statement/prospectus, SomaLogic's proxy ... Establishing ownership of stock depends on how the stock was purchased, according to the Securities and Exchange Commission. A brokerage firm may have purchased the stock or it may have been bought directly from the company.Upon the terms and subject to the conditions set forth in the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.0001 per share, of SomaLogic issued and outstanding (“SomaLogic Stock”) will be converted into the right to receive 1.11 (the “Exchange Ratio”) shares of common stock, …

SLGC | Complete SomaLogic Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.BOULDER — SomaLogic Inc. (Nasdaq: SLGC) and California-based Standard BioTools Inc. (Nasdaq: LAB) have agreed to an all-stock merger deal that is expected to result in a combined company valued at more than $1 billion. Existing executives with both companies will lead the combined organization, which will carry the Standard BioTools name.

The number of shares of Common Stock issued to Old SomaLogic stockholders was based on a deemed value of $10.00 per share after giving effect to an exchange ratio of 0.8381. Accordingly, (i) $50 million cash was paid to SomaLogic stockholders (thereby reducing the aggregate number of shares issuable under the …BOULDER, Colo., April 21, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that it will report financial results for the first quarter ...Sep 25, 2023 · The current consensus among the four polled investment analysts is to buy stock in Somalogic Inc. This rating has remained steady since January, indicating a consistent positive outlook for the company’s performance. Somalogic Inc reported earnings per share of -$0.13 for the current quarter, suggesting a loss during this period. SomaLogic, Inc. (SLGC) delivered earnings and revenue surprises of 0% and 21.48%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?Upon the terms and subject to the conditions set forth in the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.0001 per share, of SomaLogic issued and outstanding (“SomaLogic Stock”) will be converted into the right to receive 1.11 (the “Exchange Ratio”) shares of common stock, par value $0 ...Nov 28, 2022 · SomaLogic, Inc.(NASDAQ:SLGC): Well-known investor Cathie Wood has recently bought shares of healthcare company SomaLogic (SLGC) for less than $5. However, given the stock’s more than 75% fall this year, would it be a wise buy now? Read on to find out… SomaLogic Inc (NASDAQ: SLGC)’s stock price has gone rise by 4.09 in comparison to its previous close of 2.20, however, the company has experienced a 5.77% increase in its stock price over the last five trading days. GlobeNewsWire reported 2023-10-31 that BOULDER, Colo., Oct. 31, 2023 (GLOBE NEWSWIRE) — SomaLogic, Inc., a leader in proteomics […]

Summary of all time highs, changes and price drops for SomaLogic; Historical stock prices; Current Share Price: US$2.71: 52 Week High: US$3.79: 52 …

SomaLogic projects revenue for the full year 2023 to range from $80 million to $84 million. Webcast and Conference Call Details. SomaLogic will host a conference call at 4:30 p.m. ET on Tuesday, March 28, 2023 to discuss its fourth quarter 2022 financial results. Those interested in listening to the conference call should register online here ...

Oct 4, 2023 · Stockholders representing approximately 16% of Standard BioTools common stock and approximately 1% of SomaLogic common stock, including the directors and executive officers of each company and ... Stockholders representing approximately 16% of Standard BioTools common stock and approximately 1% of SomaLogic common stock, including the directors and executive officers of each company and affiliated investment funds, have entered into voting agreements in support of the transaction. Full 2023 Year OutlookWith stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.common stock and SomaLogic preferred stock held in SomaLogic’s treasury or owned by the Company, Merger Sub or SomaLogic immediately prior to the Effective Time (each an “E x c l ude d Share”), will be cancelled and no consideration will be paid or payable with respect thereto and (ii) each share of SomaLogic stock, other thanSomaLogic, Inc. is a commercial-stage proteomics company, which built an integrated proteomics platform for robust, high throughput proteomics analysis, research and clinical applications. The company was founded by Larry Gold in 2000 and is headquartered in Boulder, CO. SLGC - SomaLogic Inc - Stock screener for investors and traders, …SomaLogic shareholders will receive 1.11 shares of Standard BioTools common stock for each share of SomaLogic common stock owned. Upon the close of the deal, Standard BioTools shareholders will ...Stock control is important because it prevents retailers from running out of products, according to the Houston Chronicle. Stock control also helps retailers keep track of goods that may have been lost or stolen.View SomaLogic, Inc SLGC investment & stock information. Get the latest SomaLogic, Inc SLGC detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Dec 1, 2023 · SomaLogic last released its earnings results on November 8th, 2023. The reported ($0.12) EPS for the quarter, beating the consensus estimate of ($0.17) by $0.05. The firm had revenue of $22.05 million for the quarter, compared to analysts' expectations of $20.45 million. SomaLogic has generated ($0.69) earnings per share over the last year ... Shares of SomaLogic have tracked along with them, due to the all-stock nature of the deal, bringing SomaLogic's market capitalization down to $354.7 million, essentially the amount of cash the firm had at the end of the second quarter. "Based on stock prices, people don't seem to like this deal," said Kyle Mikson, an analyst with …Quest Diagnostics has raised a total of. $750M. in funding over 1 round. This was a Post-IPO Debt round raised on Oct 30, 2023. Quest Diagnostics is registered under the ticker NYSE:DGX . Quest Diagnostics has made 3 investments. Their most recent investment was on Nov 20, 2023, when Universal Diagnostics raised. €64.2M.

Revenue for the 3 months ended September 30, 2023, was $22 million as compared to $41.7 million in the third quarter of 2022, a 47% year-over-year decline on a GAAP basis. Excluding $22.3 million ...SomaLogic: A Look into Hedge Fund Activity and Stock Ratings SomaLogic Inc. (NASDAQ:SLGC) has recently caught the attention of large investors, as Mitchell Mcleod Pugh & Williams Inc. and Raymond James & Associates both bought new positions in the company worth $30,000 and $33,000 respectively.Stock analysis for SomaLogic Inc (CMIIU:US) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Instagram:https://instagram. hanwa co ltdnwbo stock forecast 2025h b tai dall e free Information concerning SomaLogic’s directors and executive officers, including their ownership of SomaLogic securities, is set forth in the joint proxy statement/prospectus, SomaLogic’s proxy statement for its 2023 Annual Meeting of Stockholders, which was filed with the SEC on April 25, 2023, Current Reports on Form …Like AMBP, SomaLogic stock experienced a much higher-than-average trading volume on Thursday. With more than 3.2 million shares traded, that was nearly three times the daily average volume for the last 30-days. The health-management technology company recently teamed up with Molecular Genomics to bring its 7,000-Plex SomaScan … viant dspcarvana sotck Nov 17, 2023 · The SomaLogic, Inc. stock price gained 1.62% on the last trading day (Friday, 17th Nov 2023), rising from $2.47 to $2.51. During the last trading day the stock fluctuated 3.48% from a day low at $2.44 to a day high of $2.53. The price has been going up and down for this period, and there has been a 11.06% gain for the last 2 weeks. cummins inc. stock SomaLogic share price went up by 39.55% last month. The next quarterly earnings date for SomaLogic is scheduled on March 28, 2024. SomaLogic's next ex-dividend date is November 16, 2023.SOUTH SAN FRANCISCO, Calif. and BOULDER, Colo., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose - Unleashing tools to accelerate breakthroughs in human